Desloratadine Patent Expiration

Desloratadine is used for treating symptoms of allergic rhinitis and chronic idiopathic urticaria. It was first introduced by Organon Llc A Sub Of Organon And Co in its drug Clarinex on Dec 21, 2001. 12 different companies have introduced drugs containing Desloratadine.


Desloratadine Patents

Given below is the list of patents protecting Desloratadine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Clarinex US7618649

(Pediatric)

Extended release oral dosage composition Jun 19, 2021

(Expired)

Organon
Clarinex US7618649 Extended release oral dosage composition Dec 19, 2020

(Expired)

Organon
Clarinex US6100274

(Pediatric)

8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions Jan 07, 2020

(Expired)

Organon
Clarinex US7405223

(Pediatric)

Treating allergic and inflammatory conditions Jan 07, 2020

(Expired)

Organon
Clarinex US6100274 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions Jul 07, 2019

(Expired)

Organon
Clarinex US7405223 Treating allergic and inflammatory conditions Jul 07, 2019

(Expired)

Organon
Clarinex US6514520

(Pediatric)

Stabilized antihistamine syrup Dec 01, 2018

(Expired)

Merck Sharp Dohme
Clarinex US6514520 Stabilized antihistamine syrup Jun 01, 2018

(Expired)

Merck Sharp Dohme
Clarinex US5607697

(Pediatric)

Taste masking microparticles for oral dosage forms Dec 07, 2015

(Expired)

Organon
Clarinex US7211582

(Pediatric)

Methods for treating urticaria using descarboethoxyloratadine Jun 30, 2015

(Expired)

Merck Sharp Dohme
Clarinex US7211582

(Pediatric)

Methods for treating urticaria using descarboethoxyloratadine Jun 30, 2015

(Expired)

Organon
Clarinex US7214683

(Pediatric)

Compositions of descarboethoxyloratadine Jun 30, 2015

(Expired)

Merck Sharp Dohme
Clarinex US7214683

(Pediatric)

Compositions of descarboethoxyloratadine Jun 30, 2015

(Expired)

Organon
Clarinex US7214684

(Pediatric)

Methods for the treatment of allergic rhinitis Jun 30, 2015

(Expired)

Merck Sharp Dohme
Clarinex US7214684

(Pediatric)

Methods for the treatment of allergic rhinitis Jun 30, 2015

(Expired)

Organon
Clarinex US5607697 Taste masking microparticles for oral dosage forms Jun 07, 2015

(Expired)

Organon
Clarinex US7211582 Methods for treating urticaria using descarboethoxyloratadine Dec 30, 2014

(Expired)

Merck Sharp Dohme
Clarinex US7211582 Methods for treating urticaria using descarboethoxyloratadine Dec 30, 2014

(Expired)

Organon
Clarinex US7214683 Compositions of descarboethoxyloratadine Dec 30, 2014

(Expired)

Merck Sharp Dohme
Clarinex US7214683 Compositions of descarboethoxyloratadine Dec 30, 2014

(Expired)

Organon
Clarinex US7214684 Methods for the treatment of allergic rhinitis Dec 30, 2014

(Expired)

Merck Sharp Dohme
Clarinex US7214684 Methods for the treatment of allergic rhinitis Dec 30, 2014

(Expired)

Organon



Desloratadine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Desloratadine Generic API Manufacturers

Several generic applications have been filed for Desloratadine. The first generic version for Desloratadine was by Orbion Pharmaceuticals Private Ltd and was approved on Feb 19, 2010. And the latest generic version is by Taro Pharmaceutical Industries Ltd and was approved on May 26, 2016.

Given below is the list of companies who have filed for Desloratadine generic, along with the locations of their manufacturing plants worldwide.